Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice

Free Radic Biol Med. 2022 Jun:186:17-30. doi: 10.1016/j.freeradbiomed.2022.04.019. Epub 2022 May 2.

Abstract

Oxidative damage and accumulation of extracellular matrix (ECM) components play a crucial role in the adverse outcome of cardiac hypertrophy. Evidence suggests that nuclear factor erythroid-derived factor 2 related factor 2 (Nrf2) can modulate oxidative damage and adverse myocardial remodeling. Daphnetin (Daph) is a coumarin obtained from the plant genus Daphne species that exerts anti-oxidative and anti-inflammatory properties. Herein, we investigated the roles of Daph in transverse aortic constriction (TAC)-induced cardiac hypertrophy and fibrosis in mice. TAC-induced alterations in cardiac hypertrophy markers, histopathological changes, and cardiac function were markedly ameliorated by oral administration of Daph in mice. We found that Daph significantly reduced the reactive oxygen species (ROS) generation, increased the nuclear translocation of Nrf2, and consequently, reinstated the protein levels of NAD(P)H quinone dehydrogenase1 (NQO1), heme oxygenase-1 (HO-1), and other antioxidants in the heart. Besides, Daph significantly inhibited the TAC-induced accumulation of ECM components, including α-smooth muscle actin (α-SMA), collagen I, collagen III, and fibronectin, and interfered with the TGF-β1/Smad2/3 signaling axis. Further studies revealed that TAC-induced terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive nuclei and the protein levels of Bax/Bcl2 ratio and cleaved caspase 3 were substantially decreased by Daph treatment. We further characterized the effect of Daph on angiotensin II (Ang-II)-stimulated H9c2 cardiomyoblast cells and observed that Daph markedly decreased the Ang-II induced increase in cell size, production of ROS, and proteins associated with apoptosis and fibrosis. Mechanistically, Daph alone treatment enhanced the protein levels of Nrf2, NQO1, and HO-1 in H9c2 cells. The inhibition of this axis by Si-Nrf2 transfection abolished the protective effect of Daph in H9c2 cells. Taken together, Daph effectively counteracted the TAC-induced cardiac hypertrophy and fibrosis by improving the Nrf2/HO-1 axis and inhibiting the TGF-β1/Smad2/3 signaling axis.

Keywords: Apoptosis; Myocardial fibrosis; Nrf2/HO-1 axis; TGF-β1/Smad2/3 axis; Transverse aortic constriction-induced cardiac hypertrophy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / metabolism
  • Animals
  • Cardiomegaly / drug therapy
  • Cardiomegaly / metabolism
  • Collagen / metabolism
  • Heme Oxygenase-1* / metabolism
  • Membrane Proteins* / metabolism
  • Mice
  • NF-E2-Related Factor 2* / metabolism
  • Reactive Oxygen Species / metabolism
  • Signal Transduction / drug effects
  • Smad2 Protein* / antagonists & inhibitors
  • Smad2 Protein* / metabolism
  • Smad3 Protein* / antagonists & inhibitors
  • Smad3 Protein* / metabolism
  • Transforming Growth Factor beta1* / antagonists & inhibitors
  • Transforming Growth Factor beta1* / metabolism
  • Umbelliferones* / pharmacology
  • Up-Regulation
  • Ventricular Remodeling / drug effects

Substances

  • Membrane Proteins
  • NF-E2-Related Factor 2
  • Nfe2l2 protein, mouse
  • Reactive Oxygen Species
  • Smad2 Protein
  • Smad2 protein, mouse
  • Smad3 Protein
  • Smad3 protein, mouse
  • Transforming Growth Factor beta1
  • Umbelliferones
  • Angiotensin II
  • Collagen
  • Heme Oxygenase-1
  • Hmox1 protein, mouse
  • daphnetin